Haoliang Yuan
Jiangsu Key Laboratory Of Drug Discovery For Metabolic Disease, State Key Laboratory Of Natural Medicines
Nanjing, 210009, China
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Design, synthesis, and biological evaluation of aryl urea derivatives as novel STING inhibitors based on SN-011.
Journal: Bioorganic & medicinal chemistry
Published: May 25, 2026
Design, Synthesis, and Biological Evaluation of Arylimidazole Derivatives as Potent PPARδ Agonists for the Treatment of Renal Fibrosis.
Journal: Journal of medicinal chemistry
Published: February 10, 2026
Visible-Light-Mediated Cascade Construction of Polysubstituted Naphthalene Scaffolds from 2-Methylbenzophenones and (Trifluoromethyl)alkenes.
Journal: Organic letters
Published: October 05, 2025
Discovery of indane and naphthalene derivatives as USP7 inhibitors.
Journal: European journal of medicinal chemistry
Published: April 24, 2025
Design, synthesis, and Biological evaluation of novel macrocyclic derivatives as potent ATP-citrate lyase inhibitors.
Journal: European journal of medicinal chemistry
Published: February 28, 2025
Discovery of an Orally Bioavailable STING Inhibitor with In Vivo Anti-Inflammatory Activity in Mice with STING-Mediated Inflammation.
Journal: Journal of medicinal chemistry
Published: January 28, 2025
Design, Synthesis, and Biological Evaluation of Chroman Derivatives as PD-1/PD-L1 Antagonists.
Journal: Journal of chemical information and modeling
Published: June 10, 2024
V-domain immunoglobulin suppressor of T-cell activation and programmed death receptor 1 dual checkpoint blockade enhances antitumour immunity and survival in glioblastoma.
Journal: British journal of pharmacology
Published: April 23, 2024
Design, synthesis, and biological evaluation of piperazine derivatives as pan-PPARs agonists for the treatment of liver fibrosis.
Journal: European journal of medicinal chemistry
Published: February 20, 2024
Discovery and Structural Optimization of Novel Quinolone Derivatives as Potent Irreversible Pan-Fibroblast Growth Factor Receptor Inhibitors for Treating Solid Tumors.
Journal: Journal of medicinal chemistry
Published: June 19, 2023
Discovery of the First Subnanomolar PPARα/δ Dual Agonist for the Treatment of Cholestatic Liver Diseases.
Journal: Journal of medicinal chemistry
Published: May 27, 2023
Last Updated: 09/26/2026